The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 02, 2014
Filed:
Dec. 14, 2012
Applicant:
Ligand Pharmaceuticals Inc., San Diego, CA (US);
Inventors:
Brian F. McGuinness, Plainsboro, NJ (US);
Koc-Kan Ho, Salt Lake City, UT (US);
Suresh Babu, Pennington, NJ (US);
Guizhen Dong, Dayton, NJ (US);
Jingqi Duo, Paoli, PA (US);
Thuy X. H. Le, Monmouth Junction, NJ (US);
Kurt W. Saionz, Cranford, NJ (US);
Assignee:
Ligand Pharmaceuticals Incorporated, San Diego, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/497 (2006.01); A61K 31/44 (2006.01); A61K 31/47 (2006.01); A61K 31/41 (2006.01); A61K 31/415 (2006.01); A61K 31/404 (2006.01); A61K 31/38 (2006.01); A61K 31/275 (2006.01); A61K 31/19 (2006.01); C07D 241/12 (2006.01); C07C 311/37 (2006.01); C07D 295/108 (2006.01); C07D 213/42 (2006.01); C07C 307/06 (2006.01); C07D 271/12 (2006.01); C07C 311/17 (2006.01); C07C 311/19 (2006.01); C07D 333/34 (2006.01); C07D 261/10 (2006.01); C07C 311/29 (2006.01); C07D 471/04 (2006.01); C07D 213/70 (2006.01); C07D 217/02 (2006.01); C07D 213/71 (2006.01); C07D 213/26 (2006.01); C07C 311/14 (2006.01); C07D 213/85 (2006.01); C07D 231/12 (2006.01); C07D 213/89 (2006.01); C07D 239/26 (2006.01); C07D 333/38 (2006.01); C07C 311/13 (2006.01); C07C 317/32 (2006.01); C07D 235/08 (2006.01); C07D 333/04 (2006.01); C07C 311/18 (2006.01); C07D 271/06 (2006.01); C07D 215/36 (2006.01); C07D 209/08 (2006.01); C07C 317/14 (2006.01);
U.S. Cl.
CPC ...
C07C 311/18 (2013.01); C07D 241/12 (2013.01); C07C 311/37 (2013.01); C07D 295/108 (2013.01); C07D 213/42 (2013.01); C07C 307/06 (2013.01); C07D 271/12 (2013.01); C07C 311/17 (2013.01); C07C 311/19 (2013.01); C07D 333/34 (2013.01); C07C 2101/02 (2013.01); C07D 261/10 (2013.01); C07C 311/29 (2013.01); C07D 471/04 (2013.01); C07D 213/70 (2013.01); C07D 217/02 (2013.01); C07D 213/71 (2013.01); C07D 213/26 (2013.01); C07C 311/14 (2013.01); C07D 213/85 (2013.01); C07D 231/12 (2013.01); C07D 213/89 (2013.01); C07D 239/26 (2013.01); C07D 333/38 (2013.01); C07C 311/13 (2013.01); C07C 317/32 (2013.01); C07D 235/08 (2013.01); C07D 333/04 (2013.01); C07D 271/06 (2013.01); C07D 215/36 (2013.01); C07D 209/08 (2013.01); C07C 317/14 (2013.01);
Abstract
The present invention provides biaryl oxyacetic acid compounds which may be useful for treating inflammatory disorders, including disorders affecting the respiratory system and skin. The compounds provided include those of the general formula I: